Skip to main content

Table 1 Characteristics of the patients completing the study

From: A real – life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough

Characteristics of patients (n = 14)

Variables format and values

Age [years]

Mean = 43, Standard deviation = 17

Gender [number (%)]

Females = 9 (64), Males = 5 (36)

Atopy [number (%)]

3 (14)

Total IgE [IU/mL]

Median = 69.9, Range = 28.2 ÷ 96.6

Rhinitis symptoms [number (%)]

12 (86)

GER [number (%)]

5 (36)

Duration of cough (weeks)

Mean = 27, Range = 8 ÷ 72

LCQ score before treatment

Mean = 12.4, Standard deviation = 3.36

FSSG score

Mean = 9.9, Standard deviation = 7.8

FVC% predicted before treatment

Mean = 110.6, Standard deviation = 19.9

FEV1% predicted before treatment

Mean = 111.2, Standard deviation = 19.2

EBT before treatment

Mean = 34.46, Standard deviation = 0.54